Australian equities – selective opportunities in an uneven market

owl's eye close up, macro photo, eye of the short eared owl, asio flammeus

In May CSL shares were trading at decade lows. An Australian global success story that has compounded earnings for decades was suddenly being treated by the market as damaged goods. Its enormous bounce since then without a significant change in business fundamentals, and the speed of the shift in sentiment, says more about how markets behave today than it does about CSL itself.

Global activity remains resilient, though a slowdown should be evident over the next year. Spending by higher income earners and the build out of artificial intelligence infrastructure are key support areas. Company earnings are strong, but not uniformly so. Challenges include higher energy costs, bond yields and cash rates.

Consumption in Australia has been holding up despite depleted consumer sentiment. However discretionary spending is likely to be constrained by higher interest rates and a drift higher in unemployment. Interest rate sensitive sectors are likely to be under greater pressure than those benefiting from data centre and other infrastructure investment.

In the Australian share market a large dispersion in valuation remains. Some of our larger companies appear expensive, such as in banking and resources, sectors, while several higher quality names are being overlooked.

Market short-termism is being exacerbated by the uncertain macroeconomic landscape as investors gravitate to familiar, liquid names delivering decent results now rather than those that may have a longer term or less certain payoff. A widening gap between price and underlying value is evidenced for several companies with sound long-term fundamentals but less certain short-term news flow.

Patient international fund managers with a longer investment horizon are using this dislocation to take over infrastructure entities like Qube and Atlas Arteria, drawn to their reliable inflation-linked earnings streams. Quality cash generators like Steadfast Group and Reliance Worldwide are also in their sights, businesses with resilient demand, pricing power, and strong free cash flow conversion that the broader market appears to be undervaluing amid the current bout of macro-driven uncertainty.

Volatility is likely to stay elevated because of the growing dominance of value-agnostic passive investing and quant funds which means company news that even modestly varies from expectations can trigger wild share price swings. This dynamic creates risk and opportunity for active and fundamentally focused investors. Adverse sentiment can drive share prices well below intrinsic value while positive re-ratings can happen once confidence is restored, rewarding investors with the conviction and patience to look through the noise.

Blood plasma products producer CSL’s share price action over the past year is an example of this dynamic. The market had largely given up on the stock after a series of earnings guidance downgrades drove significant share price losses. Its full-year result, released in August, was broadly in line with expectations, but guidance for the new financial year surprised on the upside. This triggered a sharp rally, including a rise of almost 40% in August alone, as active fund managers correcting underweight positions were followed by positive quant and passive flows.

Key equity sectors have contrasting outlooks. Bank share prices continue to overstate prospects for subdued earnings expansion driven by modest loan growth, slightly lifted net interest margins helped by higher cash rates and a mild rise in bad debts.

In contrast, industrials sector businesses are fertile ground for portfolio construction, particularly those that are most adaptable and able to utilise new technologies to strengthen competitive advantages.

Upside remains among healthcare stocks that the market had recently almost given up on, with durable demand from the aging population.

The heavily sold-down listed real-estate sector offers investment opportunities despite the headwinds from higher interest rates. Landlords are benefiting from the low level of new supply and ongoing population growth, supporting high occupancy levels and solid rent increases.

Opportunities also exist among technology firms with unique data sets and deep embedding in industry-specific workflows that have been swept up in indiscriminate AI-disruption selloffs.

Consumer-facing businesses outside of expensive supermarket retailers are offering more value after recent selloffs but there is chance of a further leg down if rates rise more than currently priced in by the market.

With equity returns likely to be constrained by full valuations across many areas, yield from robust cash generating businesses becomes increasingly important. Domestic interest rate sensitive businesses with little pricing power will find the road tougher in the period ahead.

For investors with the patience to look through the noise, market dispersion is where the opportunity lies. Not in the crowded, fully priced areas of the market but in fundamentally sound businesses being overlooked because of their temporary misalignment with market sentiment.

General information only and not personal financial advice.

Related articles...

Rebalancing: the discipline of buying low and selling high

1 October 2026

The Assureinvest Team

Concentration risk: When a winning position becomes a hidden danger

24 August 2026

The Assureinvest Team

Navigating higher uncertainty with greater strength

30 January 2026

Andrew Doherty

Improving fundamentals face off against elevated valuations, fuelling volatility

12 August 2025

Andrew Doherty

Trade turmoil slows growth and encourages more dramatic rate cuts

9 May 2025

Andrew Doherty

Strategic investment insights for a shifting global economy

18 February 2025

Andrew Doherty

Markets propelled by higher valuation multiples, promise of lower rates and lifted fiscal spending

5 November 2024

Andrew Doherty

Bumpy ride as economies shift to new paradigm

9 August 2024

Andrew Doherty

© 2026 AssureInvest Pty Ltd (ABN 55 636 036 188 AFSL number 478978). No part of this publication may be reproduced or distributed in any form without prior consent in writing from AssureInvest.
 
Disclaimer, General Advice Warning and Disclosure
The data, information and research commentary in this document (“Information”) may be derived from information obtained from other parties which cannot be verified by AssureInvest and therefore is not guaranteed to be complete or accurate, and AssureInvest accepts no liability for errors or omissions.
 
The Information constitutes only general advice to wholesale investors. In preparing this document, AssureInvest did not take into account your particular goals and objectives, anticipated resources, current situation or attitudes. Before making any investment decisions you should review the product disclosure statement of the relevant product and consult a securities adviser. Past performance is no guarantee of future performance. This document is not intended for publication outside of Australia.
This document is current until replaced, updated or withdrawn and will be updated if the information in it materially changes.  Please refer to the AssureInvest Financial Services Guide (FSG) for more information.
 
AssureInvest personnel may own securities referred to in this document or may acquire them in the future, and as at the date of this document.  Those interests are unlikely to be substantial in comparison with the number of securities of that type on issue. AssureInvest personnel do not receive compensation related to the information or commentary in this document.